Skip to main content
. 2021 Nov 8;47(3):759–766. doi: 10.1038/s41386-021-01223-y

Table 3.

Hazard ratios for types of psychiatric disorders among children of mothers with continued antipsychotic use during pregnancy, compared with mothers with discontinued antipsychotic use.

Antipsychotic use during pregnancya Cases Total number Person years Crude hazard ratio Adjusted hazard ratio (95% CI)b
Autism spectrum disorder
  Antipsychotic discontinuation group 114 6976 60,436 1 (ref) 1 (ref)
  Antipsychotic continuation group 26 2035 16,141 0.92 0.83 (0.53, 1.29)
Neurotic, stress related and somatoform disorders
  Antipsychotic discontinuation group 182 6976 60,053 1 (ref) 1 (ref)
  Antipsychotic continuation group 61 2035 15,832 1.43 1.08 (0.79, 1.50)
Attention deficit/hyperactivity disorders
  Antipsychotic discontinuation group 216 6976 60,086 1 (ref) 1 (ref)
  Antipsychotic continuation group 51 2035 16,035 0.95 0.85 (0.62, 1.15)
Emotional other than attention deficit/hyperactivity disorders
  Antipsychotic discontinuation group 183 6976 59,953 1 (ref) 1 (ref)
  Antipsychotic continuation group 80 2035 15,776 1.71 1.32 (0.99, 1.76)

aNote that these outcomes are not mutually exclusive as a child may receive a diagnoses within more than one disorder category.

bAdjusted for maternal age at delivery, primiparity, in- and outpatient psychiatric treatment from 2 years before pregnancy until delivery, prescriptions for other psychotropic drugs during pregnancy, number of non-psychiatric hospital visits during pregnancy, smoking during pregnancy, marital status, highest education, calendar year of delivery and paternal psychiatric history at time of delivery.